These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33247336)

  • 1. Competence to Consent to Oral and Injectable PrEP Trials Among Adolescent Males Who Have Sex with Males.
    Fisher CB; Puri LI; Macapagal K; Feuerstahler L; Ahn JR; Mustanski B
    AIDS Behav; 2021 May; 25(5):1606-1618. PubMed ID: 33247336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Free Testing and PrEP without Outing Myself to Parents:" Motivation to participate in oral and injectable PrEP clinical trials among adolescent men who have sex with men.
    Fisher CB; Fried AL; Ibrahim Puri L; Macapagal K; Mustanski B
    PLoS One; 2018; 13(7):e0200560. PubMed ID: 30044845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the Impact of PrEP Programs for Adolescent Sexual Minority Males Based on Empirical Estimates for the PrEP Continuum of Care.
    Hamilton DT; Rosenberg ES; Sullivan PS; Wang LY; Dunville RL; Barrios LC; Aslam M; Mustanski B; Goodreau SM
    J Adolesc Health; 2021 Mar; 68(3):488-496. PubMed ID: 32798099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Important steps for PrEP uptake among adolescent men who have sex with men and transgender women in Brazil.
    Soares F; Magno L; Eustorgio Filho M; Duarte FM; Grangeiro A; Greco D; Dourado I;
    PLoS One; 2023; 18(4):e0281654. PubMed ID: 37014830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence, Safety, and Feasibility of HIV Pre-Exposure Prophylaxis Among Adolescent Men Who Have Sex With Men and Transgender Women in Brazil (PrEP1519 Study).
    Dourado I; Soares F; Magno L; Amorim L; Eustorgio Filho M; Leite B; Greco D; Westin M; Tupinambás U; Massa P; Miura Zucchi E; Grangeiro A
    J Adolesc Health; 2023 Dec; 73(6S):S33-S42. PubMed ID: 37953006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Consent for HIV Prevention Research Involving Sexual and Gender Minority Youth: Reducing Barriers Through Evidence-Based Ethics.
    Fisher CB; Arbeit MR; Dumont MS; Macapagal K; Mustanski B
    J Empir Res Hum Res Ethics; 2016 Feb; 11(1):3-14. PubMed ID: 26956988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of pre-exposure prophylaxis for HIV prevention: facilitators, barriers and impact on sexual risk behaviors among men who have sex with men in Benin.
    Ahouada C; Diabaté S; Mondor M; Hessou S; Guédou FA; Béhanzin L; Batona G; Gning NN; Zannou DM; Alary M
    BMC Public Health; 2020 Aug; 20(1):1267. PubMed ID: 32819335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Willingness to take long-acting injectable pre-exposure prophylaxis among men who have sex with men who participated in the CROPrEP study: a cross-sectional online study.
    Liu Y; Chu Z; Wang H; Huang X; Chen Y; Wang H; Zou D; Jiang Y; Geng W; Hu Q; Zhou B; Shang H
    BMC Public Health; 2023 Dec; 23(1):2494. PubMed ID: 38093204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-exposure prophylaxis initiation and adherence among Black men who have sex with men (MSM) in three US cities: results from the HPTN 073 study.
    Wheeler DP; Fields SD; Beauchamp G; Chen YQ; Emel LM; Hightow-Weidman L; Hucks-Ortiz C; Kuo I; Lucas J; Magnus M; Mayer KH; Nelson LE; Hendrix CW; Piwowar-Manning E; Shoptaw S; Watkins P; Watson CC; Wilton L
    J Int AIDS Soc; 2019 Feb; 22(2):e25223. PubMed ID: 30768776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cabotegravir Extended-Release Injectable Suspension: A Review in HIV-1 Pre-Exposure Prophylaxis.
    Blair HA
    Drugs; 2022 Sep; 82(14):1489-1498. PubMed ID: 36255686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial.
    Songtaweesin WN; Kawichai S; Phanuphak N; Cressey TR; Wongharn P; Saisaengjan C; Chinbunchorn T; Janyam S; Linjongrat D; Puthanakit T;
    J Int AIDS Soc; 2020 Sep; 23 Suppl 5(Suppl 5):e25564. PubMed ID: 32869511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study.
    Marshall BDL; Goedel WC; King MRF; Singleton A; Durham DP; Chan PA; Townsend JP; Galvani AP
    Lancet HIV; 2018 Sep; 5(9):e498-e505. PubMed ID: 29908917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Pre-Exposure Prophylaxis for HIV Discontinuation in a Large Cohort of Adolescent Men Who Have Sex With Men and Transgender Women in Brazil.
    Zeballos D; Magno L; Soares F; Filho ME; Amorim L; Pinto JA; Greco D; Grangeiro A; Dourado I
    J Adolesc Health; 2023 Dec; 73(6S):S43-S49. PubMed ID: 37953008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief Report: Refusal of Daily Oral PrEP: Implementation Considerations and Reported Likelihood of Using Various HIV Prophylaxis Products in a Diverse Sample of MSM.
    Mansergh G; Kota KK; Carnes N; Gelaude D
    J Acquir Immune Defic Syndr; 2023 Mar; 92(3):212-216. PubMed ID: 36442153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zero knowledge and high interest in the use of long-acting injectable pre-exposure prophylaxis (PrEP) among adolescent men who have sex with men and transgender women in two capital cities in Brazil.
    Pedrana L; Magno L; Zucchi EM; da Silva LAV; Ferraz D; Grangeiro A; Castellanos M; Brasil SA; Dourado I
    BMC Public Health; 2022 Sep; 22(1):1728. PubMed ID: 36096758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National trends in HIV pre-exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 2017.
    Sullivan PS; Sanchez TH; Zlotorzynska M; Chandler CJ; Sineath RC; Kahle E; Tregear S
    J Int AIDS Soc; 2020 Mar; 23(3):e25461. PubMed ID: 32153119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence.
    Vuylsteke B; Reyniers T; De Baetselier I; Nöstlinger C; Crucitti T; Buyze J; Kenyon C; Wouters K; Laga M
    J Int AIDS Soc; 2019 Oct; 22(10):e25407. PubMed ID: 31663257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MSM at Highest Risk for HIV Acquisition Express Greatest Interest and Preference for Injectable Antiretroviral PrEP Compared to Daily, Oral Medication.
    Biello KB; Mimiaga MJ; Santostefano CM; Novak DS; Mayer KH
    AIDS Behav; 2018 Apr; 22(4):1158-1164. PubMed ID: 29119472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.